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Abstract—Since its renaissance, deep learning has been widely
used in various medical imaging tasks and has achieved re-
markable success in many medical imaging applications, thereby
propelling us into the so-called artificial intelligence (AI) era.
It is known that the success of AI is mostly attributed to
the availability of big data with annotations for a single task
and the advances in high performance computing. However,
medical imaging presents unique challenges that confront deep
learning approaches. In this survey paper, we first highlight both
clinical needs and technical challenges in medical imaging and
describe how emerging trends in deep learning are addressing
these issues. We cover the topics of network architecture, sparse
and noisy labels, federating learning, interpretability, uncertainty
quantification, etc. Then, we present several case studies that are
commonly found in clinical practice, including digital pathology
and chest, brain, cardiovascular, and abdominal imaging. Rather
than presenting an exhaustive literature survey, we instead
describe some prominent research highlights related to these
case study applications. We conclude with a discussion and
presentation of promising future directions.
Index Terms—Medical imaging, deep learning, survey.
I. OVERVIEW
Medical imaging [1] exploits physical phenomena such
as electromagnetic radiation, radioactivity, nuclear magnetic
resonance, and sound to generate visual representations or
images of internal tissues of the human body or a part of the
human body in a non-invasive manner. The most commonly
used imaging modalities in clinical medicine include X-ray
radiography, computed tomography (CT), magnetic resonance
imaging (MRI), and ultrasound. Imaging data account for
about 90% of all healthcare data1 and hence is one of the
most important sources of evidence for clinical analysis and
medical intervention.
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Fig. 1. The main traits of medical images and the associated technological
trends for addressing these traits.
A. Traits of medical images
As described below and illustrated in Figure 1, medical
images have several traits that influence the suitability and
nature of deep learning solutions.
Medical images have multiple modalities and are dense in
pixel resolution. There are many existing imaging modalities
and new modalities such as spectral CT are being routinely
invented. Even for commonly used imaging modalities, the
pixel or voxel resolution has become higher and the informa-
tion density has increased. For example, the spatial resolution
of clinical CT and MRI has reached the sub-millimeter level
and the spatial resolution of ultrasound is even better while its
temporal resolution exceeds real-time.
Medical images are heterogeneous and isolated. Although
medical imaging data exist in large numbers in the clinic, due
to differences in equipment, scan protocols, and the patients
themselves, their appearance is heterogeneous, leading to
the so-called “distribution drift” phenomenon. Due to patient
privacy and clinical data management requirements, images
are scattered among different hospitals and imaging centers,
and truly centralized open source medical big data are rare.
The disease patterns in medical images are numerous and
they exhibit long tail distributions. Radiology Gamuts Ontol-
ogy [2] defines 12,878 “symptoms” (conditions that lead to re-
sults) and 4,662 “diseases” (imaging findings). The incidence
of disease has a typical long-tailed distribution: while a small
number of common diseases have sufficient observed cases for
large-scale analysis, most diseases are infrequent in the clinic.
In addition, novel contagious diseases that are not represented
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2in the current ontology, such as the outbreak of COVID-19,
occur with some frequency.
The labels associated with medical images are sparse
and noisy. Labeling or annotating a medical image is time-
consuming and expensive. Also, different tasks require differ-
ent forms of annotation which creates the phenomenon of label
sparsity. Because of variable experience and different condi-
tions, both inter-user and intra-user labeling inconsistency is
high [3] and labels must therefore be considered to be noisy.
In fact, the establishment of gold standards for image labeling
remains an open issue.
Samples are imbalanced and follow a multi-modal distri-
bution. Because the appearance variations among images are
large, in the already labeled image samples, the probability
distribution from which the positive or negative samples are
drawn typically is multi-modal. The ratio between positive
and negative samples is extremely uneven. For example, the
number of pixels belonging to a tumor is usually one to many
orders of magnitude less than that of normal tissue.
Medical imaging processing and analysis tasks are complex
and diverse. Medical imaging has a rich body of tasks. At
the technical level, there is an array of technologies including
reconstruction, enhancement, restoration, classification, detec-
tion, segmentation, and registration. When these technologies
are combined with multiple image modalities and numerous
disease types, there is a very large number of highly-complex
tasks associated with numerous applications that can be de-
fined.
B. Clinical needs and applications
Medical imaging is often a key part of the medical diagnosis
and treatment process. Typically, a radiologist will review the
acquired medical images and write a summarizing report of
their findings. The referring physician will define a diagnosis
and treatment plan based on the images and radiologist’s
report. Often, medical imaging will be ordered as part of a
patient’s follow-up to verify successful treatment. In addition,
images are becoming an important component of invasive
procedures, being used both for surgical planning as well as
for real-time imaging during the procedure itself.
As a specific example we can look at what we term the
“radiology challenge”. In the past decade technology focused
on improving the image acquisition process, such that devices
have improved in speed and resolution. For example, in 1990
a CT scanner might acquire 50–100 slices whereas today’s CT
scanners might acquire 1000–2500 slices per case. A single
whole slide digital pathology image corresponding to a single
prostate biopsy core can easily occupy 10Gb of space at 40x
magnification. Overall, there are billions of medical imaging
studies conducted per year, worldwide, and this number is
growing.
Most interpretations of medical images are performed by
physicians and, in particular, by radiologists. Image interpreta-
tion by humans, however, is limited due to human subjectivity,
the large variations across interpreters, and fatigue. Radiolo-
gists that review cases have limited time to review an ever-
increasing number of images, which leads to missed findings,
long turn-around times, and a paucity of numerical results
or quantification. This, in turn, drastically limits the medical
community’s ability to advance towards more evidence-based
personalized healthcare.
AI tools such as deep learning technology can provide
support to physicians by automating image analysis, leading
to what we can term “Computational Radiology”. Among
the automated tools that can be developed are Detection of
pathological findings, Quantification of disease extent, Char-
acterization of pathologies (e.g., into benign vs malignant),
and assorted software tools that can be broadly characterized
as Decision Support. This technology can also extend physi-
cians’ capabilities to include the characterization of three-
dimensional and time-varying events, which are often not
included in today’s radiological reports because of both limited
time and limited visualization and quantification tools.
C. Key technologies and deep learning
Several key technologies arise from the various medical
imaging applications, including: [4], [5], [6], [7]
• Medical image reconstruction, which aims to form a
visual representation (aka an image) from signals ac-
quired by a medical imaging device such as a CT or
MRI scanner. Reconstruction of high quality images from
low doses and/or fast acquisitions has important clinical
implications.
• Medical image enhancement, which aims to adjust the
intensities of an image so that the resultant image is
more suitable for display or further analysis. Enhance-
ment methods include denoising, super-resolution, MR
bias field correction, and image harmonization. Recently,
much research has focused on modality translation and
synthesis, which can be considered as image enhancement
steps.
• Medical image segmentation, which aims to assign labels
to pixels so that the pixels with the same label form a seg-
mented object. Segmentation has numerous applications
in clinical quantification, therapy, and surgical planning.
• Medical image registration, which aims to align the spa-
tial coordinates of one or more images into a common co-
ordinate system. Registration finds wide use in population
analysis, longitudinal analysis, and multimodal fusion,
and is also commonly used for image segmentation via
label transfer.
• Computer aided detection (CADe) and diagnosis (CADx).
CADe aims to localize or find a bounding box that
contains an object (typically a lesion) of interest. CADx
aims to further classify the localized lesion as be-
nign/malignant or one of multiple lesion types.
• Others technologies include landmark detection, image or
view recognition, automatic report generation, etc.
In mathematics, the above technologies can be regarded as
function approximation methods, which approximate the true
mapping F that takes an image (or multiple images if mul-
timodality is accessible) as input and outputs a specific y,
y = F (x). The definition of y varies depending on the
technology, which itself depends on the application or task.
3In CADe, y denotes a bounding box. In image registration,
y is a deformation field. In image segmentation, y is a label
mask. In image enhancement, y is a quality-enhanced image
of the same size of the input image x.
There are many ways to approximate F ; however, deep
learning (DL) [8], a branch of machine learning (ML), is
one of the most powerful methods for function approximation.
Since its renaissance, deep learning has been widely used in
various medical imaging tasks and has achieved substantial
success in many medical imaging applications. Because of
its focus on learning rather than modeling, the use of DL
in medical imaging represents a substantial departure from
previous approaches in medical imaging. Take supervised
deep learning as an example. Assume that a training dataset
{(xn, yn);n = 1, . . . , N} is available and that a deep neural
network is parameterized by θ, which includes the number
of layers, the number of nodes of each layer, the connecting
weights, the choices of activation functions, etc. The neural
network that is found to approximate F can be written as
φθˆ(x) where θˆ are the parameters that minimize the so-called
loss function
L(θ) =
1
N
N∑
n=1
l(φθ(xn), yn) +R1(φθ(xn)) +R2(θ) . (1)
Here, l(φθ(x), y) is the item-wise loss function that penalizes
the prediction error, R1(φθ(xn)) reflects the prior belief about
the output, and R2(θ) is a regularization term about the
network parameters. Although the neural network φθˆ(x) does
represent a type of model, it is generally thought of as a “black
box” since it does not represent a designed model based on
well-understood physical or mathematical principles.
There are many survey papers on deep learning based key
technologies for medical image analysis [9], [10], [11], [12],
[13], [14], [15], [16], [17], [18]. To differentiate the present
review paper from these works, we specifically omit any
presentation of the technical details of DL itself, which is
no longer considered new and is well-covered in numerous
other works, and focus instead on the connections between
the emerging DL approaches and the specific needs in medical
imaging and on several case examples that illustrate the state
of the art.
D. Historical perspective
Here, we briefly outline the development timeline of DL in
medical imaging. Deep learning was termed one of the 10
breakthrough technologies of 2013 [19]. This followed the
2012 large-scale image categorization challenge, that intro-
duced the CNN superiority on the ImageNet dataset [20]. At
that point DL emerged as the leading machine-learning tool
in the general imaging and computer vision domains. At that
time, the medical imaging community began a debate about
whether DL would be applicable in the medical imaging space.
The concerns were due to the challenges we have outlined
above, with the main challenge being the lack of sufficient
labeled data, known as the Data Challenge.
Several steps can be pointed to as enablers of the DL
technology within the medical imaging space: In 2015–2016
techniques were developed using “transfer learning” (TL) (or
what was also called “learning from non-medical features”
[21]) to apply the knowledge gained via solving a source
problem to a different but related target problem. A key
question was whether a network pre-trained on natural im-
agery would be applicable to medical images? Several groups
showed this to be the case (e.g. [22], [23], [21]); using the
deep network trained based on ImageNet and fine-tuning to a
medical imaging task was helpful in order to speed up training
convergence and improve accuracy.
In 2017–2018 works emerged that were focused on a second
solution developed in the medical imaging community to pro-
cess limited datasets, which was synthetic data augmentation.
Classical augmentation is a key component of any network
training. Still, key questions to address were whether it was
possible to synthesize medical data using schemes such as
generative modeling and whether the synthesized data would
serve as viable medical examples and would in practice in-
crease performance of the medical task at hand? Several works
across varying domains demonstrated that this was in fact
the case. In [24], for example, GAN-based synthetic image
augmentation was shown to generate lesion image samples that
were not recognized as synthetic by the expert radiologists and
also increased CNN performance in classifying liver lesions.
GANs, variational encoders, and variations on these are still
being explored and advanced in recent works, as will be
described in the following Section.
For image segmentation, one of the key contributions that
emerged from the medical imaging community was the U-
Net architecture [25]. Originally designed for microscopic cell
segmentation, the U-Net has proven to efficiently and robustly
learn many medical image segmentation tasks.
E. Emerging deep learning approaches
Network architectures. Deep neural networks have a larger
model capacities and stronger generalization capabilities than
shallow neural networks. Deep models trained on large scale
annotated databases for a single task achieve outstanding
performances, far beyond traditional algorithms or even human
capability.
Making it deeper. Starting from AlexNet [20], there was
a research trend to make networks deeper, as represented by
VGGNet [26], Inception Net [27], and ResNet [28]. The use
of skip connections makes a deep network more trainable as
in DenseNet [29] and U-Net [25]. U-net was first proposed
to tackle segmentation while the other networks were devel-
oped for image classification. Deep supervision [30] further
improves discriminative power.
Adversarial and attention mechanisms. In the generative
adversarial network (GAN) [31], Goodfellow et al. propose to
accompany a generative model with a discriminator that tells
whether a sample is from the model distribution or the data dis-
tribution. Both the generator and discriminator are represented
by deep networks and their training is done via a minimax
optimization. Adversarial learning is widely used in medical
imaging [14], including medical image reconstruction [32],
image quality enhancement [33], and segmentation [34].
4Attention mechanism [35] allows automatic discovery of
“where” and “what” to focus on when describing image con-
tents or making a holistic decision. Squeeze and excitation [36]
can be regarded as a channel attention mechanism. Attention
is combined with GAN in [37] and with U-Net in [38].
Neural architecture search (NAS) and light weight design.
NAS [39] aims to automatically design the architecture of a
deep network for high performance geared toward a given task.
Zhu et al. [40] successfully apply NAS to volumetric medical
image segmentation. Light weight design [41], [42], on the
other hand, aims to design the architecture for computational
efficiency on resource-constrained devices such as mobile
phones while maintaining accuracy.
Annotation efficient approaches. To address sparse and
noisy labels, we need DL approaches that are efficient with
respect to annotations. So, a key idea is to leverage the power
and robustness of feature representation capability derived
from existing models and data even though the models or
data are not necessarily from the same domain or for the
same task and to adapt such representation to the task on
hand. To do this, there are a handful of methods proposed
in the literature [15], including transfer learning, domain
adaptation, self-supervised learning, semi-supervised learning,
weakly/partially supervised learning, etc.
Transfer learning (TL) aims to apply the knowledge gained
via solving a source problem to a different but related target
problem. One commonly used TL method is to use the deep
network trained based on ImageNet and fine tune it to a medi-
cal imaging task in order to speed up training convergence and
improve accuracy. With the availability of a large number of
annotated datasets, such TL methods [23] achieve remarkable
success. However, ImageNet consists of natural images and
its pretrained models are for 2D images only and are not
necessarily the best for medical images, especially for small-
sample settings [43]. Liu et al. [44] propose a 3D anisotropic
hybrid network that effectively transfers convolutional features
learned from 2D images to 3D anisotropic volumes. In [45],
Chen et al. combine multiple datasets from several medical
challenges with diverse modalities, target organs, and patholo-
gies and learn one 3D network that provides an effective
pretrained model for 3D medical image analysis tasks.
Domain adaptation is a form of transfer learning in which
the source and target domains have the same feature space
but different distributions. In [46], domain-invariant features
are learned via an adversarial mechanism that attempts to
classify the domain of the input data. Zhang et al. [47] pro-
pose to synthesize and segment multimodal medical volumes
using generative adversarial networks with cycle- and shape-
consistency. In [48], a domain adaptation module that maps the
target input to features which are aligned with source domain
feature space is proposed for cross-modality biomedical image
segmentation, using a domain critic module for discriminating
the feature space of both domains. Huang et al. [49] propose
a universal U-Net comprising domain-general and domain-
specific parameters that deals with multiple organ segmen-
tation tasks on multiple domains. This integrated learning
mechanism offers a new possibility of dealing with multiple
domains and even multiple heterogeneous tasks.
Fig. 2. Leveraging the anatomy knowledge embedded in CT to decompose
a chest x-ray [65].
Self-supervised learning, a form of unsupervised learning,
learns a representation through a proxy task, in which the
data provides supervisory signals. Once the representation is
learned, it is fine tuned by using annotated data. The models
genesis method [50] uses a proxy task of recovering the
original image using a distorted image as input. The possi-
ble distortions include non-linear gray-value transformation,
local pixel shuffling, and image out-painting and in-painting.
In [51], Zhu et al. proposes solving a Rubik’s Cube proxy
task that involves three operations, namely cube ordering, cube
rotating, and cube masking. This allows the network to learn
features that are invariant to translation and rotation and robust
to noise as well.
Semi-supervised learning often trains a model using a small
set of annotated images, then generates pseudo-labels for a
large set of images with annotations, and learns a final model
by mixing up both sets of images. Bai et al. [52] implements
such a method for cardiac MR segmentation. In [53], Nie et al.
proposed an attention based semi-supervised deep network for
segmentation. It adversarially trains a segmentation network,
from which a confidence map is computed as a region-
attention based semi-supervised learning strategy to include
the unlabeled data for training.
Weakly or partially supervised learning. In [54], Wang et
al. solve a weakly-supervised multi-label disease classification
from a chest x-ray. To relax the stringent pixel-wise annotation
for image segmentation, weakly supervised methods that use
image-level annotations [55], or weak annotations like dots
and scribbles [56] are proposed. For multi-organ segmentation,
Shi et al. [57] learn a single multiclass network from a union
of multiple datasets, each with a low sample size and partial
organ label, using newly proposed marginal loss and exclusion
loss. Schleg et al. [58] builds a deep model from only normal
images to detect abnormal regions in a test image.
Unsupervised learning and disentanglement. Unsupervised
learning does not rely on the existence of annotated images. A
disentangled network structure is designed with an adversarial
learning strategy that promotes the statistical matching of deep
features has been widely used. In medical imaging, unsuper-
vised learning and disentanglement have been used in image
registration [59], motion tracking [60], artifact reduction [61],
improving classification [62], domain adaptation [63], and
general modeling [64].
Embedding knowledge into learning. Knowledge arises
from various sources such as imaging physics, statistical
constraints, and task specifics and ways of embedding into a
5DL approach vary too. For chest x-ray disease classification,
Li et al. [65] encode anatomy knowledge embedded in
unpaired CT into a deep network that decomposes a chest x-
ray into lung, bone and the remaining structures (see Fig. 2).
With augmented bone-suppressed images, classification
performance is improved in predicting 11 out of 14 common
lung diseases. In [66] lung radiographs are enhanced by
learning to extract lung structures from CT based simulated
x-ray (DRRs) and fusing with the original x-ray image. The
enhancement was shown to augment results of pathology
characterization in real x-ray images. In [67], a dual-domain
network is proposed to reduce metal artifacts on both the
image and sinogram domains, which are seemingly integrated
into one differential framework through a Radon inverse
layer, rather than two separate modules.
Federated learning. To combat issues related to data data
privacy, data security, and data access rights, it has become
increasingly important to have the capability of learning a
common, robust algorithmic model through distributed com-
puting and model aggregation strategies so that no data are
transferred outside a hospital or an imaging lab. This re-
search direction is called federated learning (FL) [68], which
is in contrast to conventional centralized learning with all
the local datasets uploaded to one server. There are many
ongoing research challenges related to federate learning such
as reduced communication burden [69], data heterogeneity in
various local sites [70], and vulnerability to attacks [71].
Despite its importance, work on FL in medical imaging
has only been reported recently. Sheller et al. [72] present
the first use of FL for multi-institutional DL model without
sharing patient data and report similar brain lesion segmenta-
tion performances between the models trained in a federated
or centralized way. In [73], Li et al. study several practical
FL methods while protecting data privacy for brain tumour
segmentation on the BraTS dataset and demonstrate a trade-
off between model performance and privacy protection costs.
Recently, FL is applied, together with domain adaptation, to
train a model with boosted analysis performance and reliable
discovery of disease-related biomarkers [74].
Interpretability. Clinical decision-making relies heavily on
evidence gathering and interpretation. Lacking evidence and
interpretation makes it difficult for physicians to trust the ML
model’s prediction, especially in disease diagnosis. In addition,
interpretability is also the source of new knowledge. Murdoch
et al. [75] define interpretable machine learning as leveraging
machine-learning models to extract relevant knowledge about
domain relationships contained in data, aiming to provide
insights for a user into a chosen domain problem. Most inter-
pretation methods are categorized as model-based and post-hoc
interpretability. The former is about constraining the model so
that it readily provides useful information (such as sparsity,
modularity, etc.) about the uncovered relationships. The latter
is about extracting information about what relationships the
model has learned.
Model-based interpretability. For cardiac MRI classifica-
tion [76], diagnostically meaningful concepts in the latent
space are encoded. In [77], when training the model for healthy
and hypertrophic cardiomyopathy classification, it leverages
interpretable task-specific anatomic patterns learned from 3D
segmentations.
Post-hoc interpretability. In [78], the feature importance
scores are calculated for graph neural network by comparing
its interpretation ability with Random Forest. Li et al. [79]
propose a brain biomarker interpretation method through a
frequency-normalized sampling strategy to corrupt an image.
In [80], various interpretability methods are evaluated in the
context of semantic segmentation of polyps from colonoscopy
images. In [81], a hybrid RBM-Random Forest system on
brain lesion segmentation is learned with the goal of enhancing
interpretability of automatically extracted features.
Uncertainty quantification characterizes the model predic-
tion with confidence measure [82], which can be regarded
as a method of post-hoc interpretability, even though of-
ten the uncertainty measure is calculated along with the
model prediction. Recently there are emerging works that
quantify uncertainty in deep learning methods for medical
image segmentation [83], [84], [85], lesion detection [86],
chest x-ray disease classification [87], and diabetic retinopathy
grading [88], [89]. One additional extension to uncertainty is
its combination with the knowledge that the given labels are
noisy. Works are now starting to emerge that take into account
label uncertainty in the modeling of the network architecture
and its training [90].
II. CASE STUDIES WITH PROGRESS HIGHLIGHTS
Given that DL has been used in a vast number of medi-
cal imaging applications, it is nearly infeasible to cover all
possible related literature in a single paper. Therefore, we
cover several selected cases that are commonly found in
clinical practices, which include chest, neuro, cardiovascular,
abdominal, and microscopy imaging. Further, rather than pre-
senting an exhaustive literature survey for each studied case,
we provide some prominent progress highlights in each case
study.
A. Deep learning in thoracic imaging
Lung diseases have a high mortality and morbidity. In the
top ten causes of death worldwide we find lung cancer, chronic
obstructive pulmonary disease (COPD), pneumonia, and tuber-
culosis (TB). At the moment of writing this overview, COVID-
19 has a death rate comparable to TB. Imaging is highly
relevant to diagnose, plan treatment and learn more about
the causes and mechanisms underlying these and other lung
diseases. Next to that, pulmonary complications are common
in hospitalized patients. As a result, chest radiography is by far
the most common radiological examination, often comprising
over a third of all studies in a radiology department.
Plain radiography and computed tomography are the two
most common modalities to image the chest. The high contrast
in density between air-filled lung parenchyma and tissue makes
CT ideal for in vivo analysis of the lungs, obtaining high-
quality and high-resolution images even at very low radiation
dose. Nuclear imaging (PET or PET/CT) is used for diagnos-
ing and staging of oncology patients. MRI is somewhat limited
in the lungs, but can yield unique functional information.
6Ultrasound imaging is also difficult because sound waves
reflect strongly at boundaries of air and tissue, but point-
of-care ultrasound is used at the emergency department and
is widely used to monitor COVID-19 patients for which the
first decision support applications based on deep learning have
already appeared [91].
Segmentation of anatomical structures. For analysis and
quantification from chest CT scans, automated segmentation
of major anatomical structures is an important prerequisite.
Recent publications demonstrate convincingly that deep learn-
ing is now the state-of-the-art method to achieve this. This is
evident from inspecting the results of LOLA112, a competition
started in 2011 for lung and lobe segmentation in chest CT.
The test dataset for this challenge included many challenging
cases with lungs affected by severe abnormalities. For years,
the best results were obtained by interactive methods. In 2019
and 2020, seven fully automatic methods based on U-Nets
or variants thereof made the top 10 for lung segmentation,
and for lobe segmentation, two recent methods obtained re-
sults outperforming the best interactive methods. Both these
methods [92], [93] were trained on thousands of CT scans
from the COPDGene study [94], illustrating the importance
of large high quality datasets to obtain good results with
deep learning. This data is publicly available on request. Both
methods used a multi-resolution U-net like architecture with
several customizations. Gerard et al. integrated a previously
developed method for finding the fissures [95]. Xie et al. [93]
added a non-local module with self-attention and finetuned
their method on data of COVID-19 suspects to accurately
segment the lobes in scans affected by ground-glass and
consolidations.
Segmentation of the vasculature, separated in to arteries and
veins, and the airway tree, including labeling of the branches
and segmentation of the bronchial wall, is another important
area of research. Although methods that use convolutional
networks in some of their steps have been proposed, devel-
oping an architecture entirely based on deep learning that
can accurately track and segment intertwined tree structures
and take advantage of the known geometry of these complex
structures, is still an open challenge.
Detection and diagnosis in chest radiography. Recently the
number of publications on detecting abnormalities in the
ubiquitous chest x-ray has increased enormously. This trend
has been driven by the availability of large public datasets,
such as ChestXRay14 [54], CheXpert [96], MIMIC [97] and
PadChest [98], totaling 868k images. Labels for presence or
absence of over 150 different abnormal signs were gathered by
text-mining the accompanying radiology reports. This makes
the labels noisy. Most publications use a standard approach of
inputting the entire image in a popular convolutional network
architecture. Methodological contributions include novel ways
of preprocessing the images, handling the label uncertainty and
the large number of classes, suppressing the bones [65], and
exploiting self-supervised learning as a way of pretraining. So
far, only few publications analyze multiple exams of the same
patient to detect interval change or analyze the lateral views.
2https://lola11.grand-challenge.org/
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Fig. 3. Example output of the CORADS-AI system for a COVID-19 case. Top
row shows coronal slices, the second row shows lobe segmentation and bottom
row shows detected abnormal areas of patchy ground-glass and consolidation
typical for COVID-19 infection. The CO-RADS prediction and CT severity
score per lobe are displayed below the images.
Decision support in lung cancer screening. Following the
positive outcome of the NLST trial, the United States has
started a screening program for heavy smokers for early
detection of lung cancer with annual low-dose CT scans. Many
other countries worldwide are expected to follow suit. In the
United States, screening centers have to use a reporting system
called Lung-RADS [99]. Reading lung cancer screening CT
scans is time consuming and therefore automating the various
steps in Lung-RADS has received a lot of attention.
The most widely studied topic is nodule detection [100].
Nodules may represent lung cancer. Many DL systems were
compared in the LUNA16 challenge3. Lung-RADS classifies
scans in categories based on the most suspicious nodule,
and this is determined by the nodule type and size. DL
systems to determine nodule type have been proposed [101]
and measuring the size can be done by traditional methods
based on thresholding and mathematical morphology but also
with DL networks. Finally, Lung-RADS contains the option
to directly refer scans with a nodule that is highly suspicious
for cancer. Many DL systems to estimate nodule malignancy
have been proposed.
The advantage of automating the LUNG-RADS guidelines
step-by-step is that this leads to an explainable AI solution that
can directly support radiologists in their reading workflow.
Alternatively, one could ask a computer to directly predict
if a CT scan contains an actionable lung cancer. This was
the topic of a Kaggle challenge organized in 20174 in which
almost 2000 teams competed for a one million dollar prize
purse. The top 10 solutions all used deep learning and are
open source. Two years later, a team from Google published an
implementation [102] following the approach of the winning
team in the Kaggle challenge, employing modern architectures
such as a 3D inflated Inception architecture (I3D) [103]. The
I3D architecture builds upon the Inception v1 model for 2D
3https://luna16.grand-challenge.org/
4https://www.kaggle.com/c/data- science-bowl-2017/
7image classification but inflates the filters and pooling kernels
into 3D. This enables the use of an image classification model
pre-trained with 2D data for a 3D image classification task.
The paper showed that the model outperformed six radiologists
that followed Lung-RADS. The model was also extended to
handle follow-up scans where it obtained performance slightly
below human experts.
COVID-19 case study. As an illustration how DL with pre-
trained elements can be used to rapidly build applications,
we briefly discuss the development of two tools for COVID-
19 detection, for chest radiographs and chest CT. In March
2020, many European hospitals were overwhelmed by pa-
tients presenting at the emergency care with respiratory com-
plaints. There was a shortage of molecular testing capacity for
COVID-19 and turnaround time for test results was often days.
Hospitals therefore used chest x-ray or CT to obtain a working
diagnosis and decide whether to hospitalize patients and how
to treat them. In just six weeks, researchers from various Dutch
and German hospitals, research institutes and a company
managed to create a solution for COVID-19 detection from
an x-ray and from a CT scan. Figure 3 shows the result of
this CORADS-AI system for a COVID-19 positive case.
The x-ray solution started from a convolutional network
using local and global labels, pretrained to detect tuberculo-
sis [104], finetuned using public and private data of patients
with and without pneumonia to detect pneumonia in general,
and subsequently finetuned on x-ray data from patients of
a Dutch hospital in a COVID-19 hotspot. The system was
subsequently evaluated on 454 chest radiographs from another
Dutch hospital and shown to perform comparably to six chest
radiologists [105]. The system is currently being field tested
in Africa.
The CT solution, called CO-RADS [106], aimed to auto-
mate a clinical reporting system for CT of COVID-19 suspects.
This system assesses the likelihood of COVID-19 infection
on a scale from CO-RADS 1 (highly unlikely) to CO-RADS
5 (highly likely) and quantifies the severity of disease using
a score per lung lobe from 0 to 5 depending on percentage
affected lung parenchyma for a maximum CT severity score of
25 points. The previously mentioned lobe segmentation [93]
was employed. Abnormal areas in the lung were segmented
using a 3D U-net built with the nnU-Net framework [107] in
a cross-validated fashion with 108 scans and corresponding
reference delineations to segment ground-glass opacities and
consolidation in the lungs. The CT severity score was derived
from the segmentation results by computing the percentage
of affected parenchymal tissue per lobe. nnU-Net was com-
pared with several other approaches and performed best. For
assessing the CO-RADS score, the previously mentioned I3D
architecture [103] performed best.
B. Deep learning in neuroimaging
In recent years, deep learning has seen a dramatic rise
in popularity within the neuroimaging community. Many
neuroimaging tasks including segmentation, registration, and
prediction now have deep learning based implementations.
Additionally, through the use of deep generative models and
Fig. 4. Cerebellum parcellation by the ACAPULCO cascaded deep networks
method. Lobule labels are shown for (A) a healthy subject and subjects with
(B) spinocerebellar ataxia (SCA) type 2, (C) SCA type 3, and (D) SCA type
6 [109].
adversarial training, deep learning has enabled new avenues of
research in complex image synthesis tasks. With the increasing
availability of large and diverse pooled neuroimaging stud-
ies, deep learning offers interesting prospects for improving
accuracy and generalizability while reducing inference time
and the need for complex preprocessing. CNNs, in particular,
have allowed for efficient network parameterization and spatial
invariance, both of which are critical when dealing with high-
dimensional neuroimaging data. The learnable feature reduc-
tion and selection capabilities of CNNs have proven effective
in high level prediction and analysis tasks and has reduced
the need for highly specific domain knowledge. Specialized
networks such as U-nets [25], V-nets [108], and GANs [31]
are also popular in neuroimaging, and have been leveraged for
a variety of segmentation and synthesis tasks.
Neuroimage segmentation and tissue classification. Accu-
rate segmentation is an important preprocessing step that
informs much of the downstream analytic and predictive
tasks done in neuroimaging. Commonly used tools such as
FreeSurfer [110] rely on atlas based methods, whereby an
atlas is deformably registered to the scan, which requires time
consuming optimization problems to be solved. Proposed deep
learning based approaches, however, are relatively compu-
tationally inexpensive during inference. Recent research has
focused on important tasks such as deep learning based brain
extraction [111], cortical and subcortical segmentation [112],
[113], [114], [115], and tumor and lesion segmentation [116],
[117]. Some interesting research has looked at improving the
generalization performance of deep learning based segmenta-
tion methods across neuroimaging datasets imaged at different
8scanners. In particular, Kamnitsas et al. [46] has proposed a
training schema which leverages adversarial training to learn
scanner invariant feature representations. They use an adver-
sarial network to classify the origin of the input data based on
the downstream feature representation learned by the segmen-
tation network. By penalizing the segmentation network for
improved performance of the adversarial network, they show
improved segmentation generalization across datasets. Brain
tumor segmentation has been another active area of research in
the neuroimaging community where deep learning has shown
promise. In the past, brain tumor datasets have remained
relatively small, particularly ones with subjects imaged at a
single institution. The Brain Tumor Segmentation Challenge
(BraTS) [118] has provided the community with an accessible
dataset as well as a way to benchmark various approaches
against one another. While it has been seen that deep learn-
ing has difficulty in training on datasets with relatively few
scans, new architectures and training methods are becoming
increasingly effective at this. Havaei et al. [116] demonstrate
the performance of their glioblastoma segmentation network
on the BraTS dataset, achieving high accuracy while being
substantially faster than previous methods. Another task where
deep networks are finding increasing success is semantic
segmentation in which anatomical labels are not necessarily
well-defined by image intensity changes but can be identified
by relative anatomical locations. A good example is that of
cerebellum parcellation where deep networks performed best
in a recent comparison of methods [119]. The even newer
ACAPULCO method [109] uses two cascaded deep networks
to produce cerebellar lobule labels, as shown in Figure 4.
Deformable image registration. Image registration allows
for imaging analysis in a single subject across imaging
modalities and time points. Deep learning based deformable
registration with neuroimaging data has proven to be a difficult
problem, especially considering the lack of ground truth. Still,
some unique and varied approaches have achieved state-of-the-
art results with relatively fast run times [120], [121], [122],
[123]. Li et al. [121] propose a fully convolutional “self-
supervised” approach to learn the appropriate spatial trans-
formations at multiple resolutions. Balakrishnan et al. [120]
propose a method for unsupervised image registration which
attempts to directly compute the deformation field.
Neuroimaging prediction. With many architectures being
borrowed from the computer vision community, deep learn-
ing based prediction in neuroimaging has quickly gained
popularity. Traditionally, machine learning based prediction
on neuroimaging data has relied on careful feature selec-
tion/engineering; often taking the form of regional summary
measures which may not account for all the informative
variation for a particular task. Whereas, in deep learning,
it is common to work with raw imaging data, where the
appropriate feature representations can be learned through
optimization. This can be particularly useful for high-level
prediction tasks in which we do not know what imaging
features will be informative. Further, by working on the raw
image, reliance on complex and time consuming preprocessing
can be reduced. In recent years, a large amount of work
has been published on deep learning based prediction tasks
such as brain age prediction [124], [125], [126], Alzheimer’s
disease classification and trajectory modeling [127], [128],
[129], [130], and schizophrenia classification [131], [132].
Some work has considered the use of deep Siamese networks
for longitudinal image analysis. Siamese networks have gained
popularity for their success in facial recognition. They work
by jointly optimizing a set of weights on two images with
respect to some distance metric between them. This setup
makes them effective at identifying longitudinal changes on
some chosen dimension. Bhagwat et al. [133] consider the use
of longitudinal Siamese network for the prediction of future
Alzheimer’s disease onset, using two early time points. They
show substantially improved performance in identifying future
Alzheimer’s cases, with the use of two time points versus only
a baseline scan.
The use of GANs in neuroimaging. GANs have enabled
complex image synthesis tasks in neuroimaging, many of
which have no comparable analogs in traditional machine
learning. GANs and their variants have been used in neu-
roimaging for cross-modality synthesis [134], motion artifact
reduction [135], resolution upscaling [136], [137], [138], esti-
mating full-dosage PET images from low-dosage PET [139],
[140], [141], image harmonization [33], [142], heterogeneity
analysis [143], and more. To help facilitate such work, the
popular MedGAN [144] proposes a series of modifications
and new loss functions to traditional GANs, aimed at preserv-
ing anatomically relevant information and fine details. They
use auxiliary classifiers on the translated image to ensure
the resulting image feature representation is similar to the
expected image representation for a given task. Additionally,
they use style-transfer loss in combination with adversarial loss
to ensure fine structures and textural details are matched in
the translation. Some promising new work attempts to reduce
the amount of radioactive tracer needed in PET imaging,
potentially reducing associated costs and health risks. This
problem can be framed as an image synthesis task, whereby
the final image can be synthesized from the low dose image.
In [145], the pixel location information is integrated into a
deep network for image synthesis. Kaplan and Zhu [141]
propose a deep generative based denoising method, that uses
paired scans of subjects imaged with both low and full dose
PET. They show that despite a ten-fold reduction in tracer
material, they are able to preserve important edge, structural,
and textural details. Consistent quantification in neuroimaging
has been hampered for decades by the high variability in MR
image intensities and resolutions between scans. Dewey et
al. [33] use a U-Net style architecture and paired subjects
who have been scanned with two different protocols, to learn
a mapping between the two sites. Resolution differences are
addressed by applying a super-resolution method to the images
acquired at lower resolutions [146]. They are able to use
the network to reduce site based variation, which improves
consistency in segmentation between the two sites.
While deep learning in neuroimaging has certainly opened
up many interesting avenues of investigation, certain areas
still lack a rigorous understanding. Important lines of research
such as learning from limited data, optimal hyperparameter
selection, domain adaptation, semi-supervised designs, and
9improving robustness require further investigation.
C. Deep learning in cardiovascular imaging
The quantification and understanding of cardiac anatomy
and function has been transformed by the recent progress in the
field of data-driven deep learning. There has been significant
recent work in a variety of sub-areas of cardiovascular imaging
including image reconstruction [147], end-to-end learning of
cardiac pathology from images [148] and incorporation of non-
imaging information (e.g. genetics [149] and clinical informa-
tion) for analysis. Here we briefly focus on three key aspects
of deep learning in this field: cardiac chamber segmentation,
cardiac motion/deformation analysis and analysis of cardiac
vessels. Motion tracking and segmentation both play crucial
roles in the detection and quantification of myocardial chamber
dysfunction and can help in the diagnosis of cardiovascular
disease (CVD). Traditionally, these tasks are treated uniquely
and solved as separate steps. Often times, motion tracking
algorithms use segmentation results as an anatomical guide
to sample points and regions of interest used to generate dis-
placement fields e.g. [150]. In part due to this, there have also
been efforts to combine motion tracking and segmentation.
Cardiac image segmentation is an important first step for
many clinical applications. The aim is typically to segment
the main chambers, e.g. the left ventricle (LV), right ventricle
(RV), left atrium (LA) and right atrium (RA). This enables
the quantification of parameters that describe cardiac morphol-
ogy, e.g. LV volume or mass, or cardiac function, e.g. wall
thickening and ejection fraction. There has been significant
deep learning work on cardiac chamber segmentation, mostly
characterized by the type of images (modalities) employed and
whether the work is in 2D or 3D. One of the first efforts to
apply a fully convolutional network (FCN) [151] to segment
the left ventricle (LV), myocardium and right ventricle from
2D short-axis cardiac magnetic resonance (MR) images was
done by Tran [152], significantly outperforming traditional
methods in accuracy and speed. Since this time, a variety of
other FCN-based strategies have been developed [153], espe-
cially focusing on the popular U-Net approach, often including
both 2D and 3D constraints (e.g. [154]). The incorporation
of spatial and temporal context has also been an important
research direction, including efforts to simultaneously segment
the heart in both the end-diastolic and end-systolic states [155].
Shape-based constraints had previously been found useful for
LV chamber segmentation using other types of machine learn-
ing (e.g. [156]) and were nicely included in an anatomically-
constrained deep learning strategy by [157]. This stacked
convolutional autoencoder approach was successfully applied
to LV segmentation from 3D echocardiography data as well.
Other important work has been aimed at atrial segmentation
from MRI [158], whole heart segmentation from CT [159]
and LV segmentation from 3D ultrasound image sequences
(e.g. [160]), the latter using a combination of atlas registration
and adversarial learning. Progress in deep learning for cardiac
segmentation is enabled by a number of ongoing challenges
in the field (e.g. [161], [162]).
Cardiac motion tracking is key for deformation/strain anal-
ysis and is important for analyzing the mechanical perfor-
Fig. 5. Top: 4D two-channel CNN architecture for joint LV motion track-
ing/segmentation network; Bottom: 2D echocardiography slices through 3D
canine results (left = displacements with ground truth interpolated from
sonomicrometer crystals; right = LV endocardial (red) and epicardial (green)
segmented boundaries with ground truth from human expert tracing.) Repro-
duced from [163].
mance of heart chambers. A variety of image registration,
feature-based tracking and regularization methods using both
biomechanical models and data-driven learning have been
developed. One special type of dataset useful for tracking
are MRI tagging acquisitions, and deep learning has recently
played a role in tracking these tags and quantifying the dis-
placement information for motion tracking and analysis [164]
using a combination of recurrent neural networks (RNNs) and
convolutional neural netorks (CNNs) to estimate myocardial
strain from short axis MR tag image sequences. Estimating
motion displacements and strain is also possible to do from
both standard MR image sequences and 4D echocardiography,
most often by integrating ideas of image segmentation and
mapping between frames using some type of image registra-
tion. Recent efforts for cardiac motion tracking from magnetic
resonance (MR) imaging have adopted approaches from the
computer vision field that suggest that the tasks of motion
tracking and segmentation are closely related and information
used to complete one task may complement and improve the
overall performance of the other. In particular, an interesting
deep learning approach proposed for joint learning of video
object segmentation and optical flow (motion displacements) is
termed SegFlow [165], an end-to-end unified network that si-
multaneously trains both tasks and exploits the commonality of
these two tasks through bi-directional feature sharing. Among
the first to integrate this idea into cardiac analysis was Qin et
al. [60], who successfully implemented the idea of combining
motion and segmentation on 2D cardiac MR sequences by
developing a dual Siamese style recurrent spatial transformer
network and fully convolutional segmentation network to
simultaneously estimate motion and generate segmentation
masks. This work was mainly aimed at 2D MR images,
which have higher SNR than echocardiographic images and,
therefore, more clearly delineated LV walls. It remains chal-
lenging to directly apply this approach to echocardiography.
Very recent efforts by Ta et al. [163] (see Fig. 5) propose a
4D (3D+t) semi-supervised joint network to simultaneously
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track LV motion while segmenting the LV wall. The network
is trained in an iterative manner where results from one
branch influence and regularize the other. Displacement fields
are further regularized by a biomechanically-inspired incom-
pressibility constraint that enforces realistic cardiac motion
behavior. The proposed model is different from other models
in that it expands the network to 4D in order to capture out of
plane motion. Finally, clinical interpretability of deep learning-
derived motion information will be an important topic in the
years ahead (e.g. [166]).
Cardiac vessel segmentation is another important task for
cardiac image analysis and includes the segmentation of the
vessels including the great vessels (e.g. aorta, pulmonary
arteries and veins) as well as the coronary arteries. The
segmentation of large vessels such as the aorta is important for
accurate mechanical and hemodynamic characterization, e.g.
for assessment of aortic compliance. Several deep learning
approaches have been proposed for this segmentation task,
including the use of recurrent neural networks in order to
track the aorta in cardiac MR image sequences in the presence
of noise and artefacts [167]. A similarly important task is
the segmentation of the coronary arteries as a precursor to
quantitative analysis for the assessment of stenosis or the
simulation of blood flow simulation for the calculation of
fractional flow reserve from CT angiography (CTA). The
approaches for coronary artery segmentation can be divided
into those approaches that extract the vessel centerline and
those that segment the vessel lumen.
One end-to-end trainable approach for the extraction of the
coronary centerline has been proposed in [168]. In this ap-
proach the centerline is extracted using a multi-task fully con-
volutional network which simultaneously computes centerline
distance maps and detects branch endpoints. The method gen-
erates single-pixel-wide centerlines with no spurious branches.
An interesting aspect of this technique is that it can handle
an arbitrary vessel tree with no prior assumption regarding
depth of the vessel tree or its bifurcation pattern. In contrast
to this, Wolterink et al. [169] propose a CNN that is trained
to predict the most likely direction and radius of the coronary
artery within a local 3D image patch. Starting from a seed
point, the coronary artery is tracked by following the vessel
centerline using the predictions of the CNN.
Alternative approaches to centerline extraction are based on
techniques that instead aim to segment the vessel lumen, e.g.
using CNN segmentation methods that perform segmentation
by predicting vessel probability maps. One elegant approach
has been proposed by Moeskops et al. [170]: Here a single
CNN is trained to perform three different segmentation tasks
including coronary artery segmentation in cardiac CTA. In-
stead of performing voxelwise segmentation, Lee et al. [171]
introduce a tubular shape prior for the vessel segments. This
is implemented via a template transformer network, through
which a shape template can be deformed via network-based
registration to produce an accurate segmentation of the input
image, as well as to guarantee topological constraints.
More recently, geometric deep learning approaches have
also been applied for coronary artery segmentation. For exam-
ple, Wolterink et al. [172] used graph convolutional networks
Fig. 6. Example universal lesion detector for abdominal CT. In this axial
image through the upper abdomen, a liver lesion was correctly detected with
high confidence (0.995). A renal cyst (0.554) and a bone metastasis (0.655)
were also detected correctly. False positives include normal pancreas (0.947),
gallbladder (0.821), and bowel (0.608). A subtle bone metastasis (blue box)
was missed. Reproduced from [174].
for coronary artery segmentation. Here vertices on surface of
the coronary artery are used as graph nodes and their locations
is optimized in an end-to-end fashion.
D. Deep learning in abdominal imaging
Recently there has been an accelerating progress in auto-
mated detection, classification and segmentation of abdominal
anatomy and disease using medical imaging. Large public data
sets such as the MICCAI Data Decathlon and Deep Lesion
data sets have facilitated progress [173], [174].
Organs and lesions. Multi-organ approaches have been pop-
ular methods for anatomy localization and segmentation [175].
For individual organs, the liver, prostate and spine are arguably
the most accurately segmented structures and the most actively
investigated with deep learning. Other organs of interest to
deep learning researchers include pancreas, lymph nodes and
bowel.
A number of studies have used U-Net to segment the
liver and liver lesions and assess for hepatic steatosis [176],
[177], [178]. Dice coefficients for liver segmentation typically
exceed 95%. In the prostate, gland segmentation and lesion
detection has been the subject of an SPIE/AAPM challenge
(competition) and numerous publications [179], [180]. Several
groups have used data sets such as TCIA CT pancreas to
improve pancreas segmentation with Dice coefficients reaching
the mid 80 percentile [181], [182], [183], [184]. Automated de-
tection of pancreatic cancer using deep learning has also been
reported [184]. Deep learning has been used for determining
pancreatic tumor growth rates in patients with neuroendocrine
tumors of the pancreas [185]. The spleen has been segmented
with a Dice score of 0.962 [186]. Recently marginal loss and
exclusion loss [57] have been proposed to train a single multi-
organ segmentation network from a union of partially labelled
datasets.
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Enlarged lymph nodes can indicate the presence of inflam-
mation, infection, or metastatic cancer. Studies have assessed
abdominal lymph nodes on CT in general and for specific
diseases such as prostate cancer [187], [22], [188]. The TCIA
CT lymph node dataset has enabled progress in this area [189].
In the bowel, CT colonography computer-aided polyp de-
tection was a hot topic in abdominal CT image analysis over
a decade ago. Recent progress with deep learning has been
limited but studies have reported improved electronic bowel
cleansing, and higher sensitivities and lower false-positive
rates for precancerous colonic polyp detection [187], [190].
Deep learning using persistent homology has recently shown
success for small bowel segmentation on CT [191]. Colonic
inflammation can be detected on CT with deep learning [192].
Appendicitis can be detected on CT scans by pre-training with
natural world videos [193]. The Inception V3 convolutional
neural network could detect small bowel obstruction on ab-
dominal radiographs [194].
Kidney function can be predicted using deep learning of
ultrasound images [195]. Potentially diffuse disorders such as
ovarian cancer and abnormal blood collections were detectable
using deep learning [196], [197]. Organs at risk for radiation
therapy of the male pelvis, such as bladder and rectum, have
been segmented on CT using U-Net [198].
Universal lesion detectors [174], [199] have been developed
for body CT including abdominal CT (Figure 6). The universal
lesion detector identifies, classifies and measures lymph nodes
and a variety of tumors throughout the abdomen. This detector
was trained using the publicly available Deep Lesion data set.
Opportunistic screening to quantify and detect under-
reported chronic diseases has been an area of recent interest.
Example deep learning methods for opportunistic screening in
the abdomen include automated bone mineral densitometry,
visceral fat assessment, muscle volume and quality assessment,
and aortic atherosclerotic plaque quantification [200]. Studies
indicate that these measurements can be done accurately and
generalize well to new patient populations. These opportunistic
screening assessments also enable prediction of survival and
cardiovascular morbidity such as heart attack and stroke [200].
Deep learning for abdominal imaging is likely to continue
to advance rapidly. For translation to the clinic, some of the
most important advances sought will be in demonstrating gen-
eralizability across different patient populations and variations
in image acquisition.
E. Deep learning in microscopy imaging
With the advent of whole slide scanning and the devel-
opment of large digital datasets of tissue slide images, there
has been a significant increase in application of deep learning
approaches to digital pathology data [201]. While the initial
application of these approaches in the area of digital pathology
primarily focused on its utility for detection and segmentation
of individual primitives like lymphocytes and cancer nuclei,
they have now progressed to addressing higher level diagnostic
and prognostic tasks and also the application of DL approaches
to predict the underlying molecular underpinning and muta-
tional status of the disease. Briefly below we describe the
evolving applications of DL approaches to digital pathology.
Fig. 7. Application of deep learning for identifying cancerous regions from
whole slide images as well as for identifying and segmenting different types
of nuclei within the whole slide pathology images.
Nuclei detection and segmentation. One of the early ap-
plications of DL to whole slide pathology images was in
the detection and segmentation of individual nuclei. Xu et
al. [202] presented an approach using stacked spare auto-
encoder approach to identify the location of individual can-
cer nuclei on breast cancer pathology images. Subsequently
work from Janowczyk et al. [203] demonstrated the utility of
DL approaches for identifying and segmenting a number of
different histologic primitives including lymphocytes, tubules,
mitotic figures, cancer extent and also for classifying different
disease categories pertaining to leukemia. The comprehensive
tutorial also went into great detail with regard to best practices
for annotation, network training and testing protocols. Subse-
quently Cruz-Roa et al. demonstrated that convolutional neural
networks could be applied for accurately identifying cancer
presence and extent on whole slide breast cancer pathology
images [204]. The approach was shown to have a 100%
accuracy at identifying the presence or absence of cancer
on a slide or patient level. Subsequently Cruz-Roa et al also
demonstrated the use of a high-throughput adaptive sampling
approach for improving the efficiency of the CNN presented
previously in [205]. In [206] Veta and colleagues discussed the
diagnostic assessment of DL algorithms for detection of lymph
node metastases in women with breast cancer, as part of the
CAMELYON16 challenge. The work found that at least 5 DL
algorithms performed comparably to a pathologist interpreting
the slides in the absence of time constraints and that some
DL algorithms achieved better diagnostic performance than a
panel of 11 pathologists participating in a simulation exercise
designed to mimic a routine pathology workflow. In a related
study of lung cancer pathology images, Coudray et al. [207]
trained a deep CNN (inception V3) on WSIs from The Cancer
Genome Atlas (TCGA) to accurately and automatically clas-
sify them into lung adenocarcinoma, squamous cell carcinoma
or normal lung tissue, yielding an area under the curve of 0.97.
One of the challenges with the CNN based approaches
described in [204], [205], [206], [207] is the need for detailed
annotations of the target of interest. This is a labor intensive
task given that annotations of disease extent typically need to
be provided by pathologists who have a minimal amount of
time to begin with. In a comprehensive paper by Campanella
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et al. [208], the team employed a weakly supervised approach
for training a deep learning algorithm for identifying the
presence or absence of cancer on a slide level. They were
able to demonstrate on a large scale study of over 44K WSIs
from over 15K patients, that for prostate cancer, basal cell
carcinoma and breast cancer metastases to axillary lymph
nodes, the corresponding areas under the curve were all above
0.98. The authors suggested that the approach could be used
by pathologists to exclude 65-75% of slides while retaining
100% cancer detection sensitivity.
Disease grading. Pathologists can reliably identify disease
type and extent on H&E slides and have made observations for
decades that there are features of disease that correlate with its
behavior. However they are unable to reproducibly identify or
quantify these histologic hallmarks of disease behavior with
enough rigor, to use these features routinely to dictate disease
outcome and treatment response. One of the areas that DL has
been applied has been to try and mimic pathologist’s identifi-
cation of disease hallmarks, especially in the context of cancer.
For instance in prostate cancer pathologists typically aim to
place the cancer into one of 5 different categories, referred
to as the Gleason grade groups [209]. However this grading
system, as with many other cancers and diseases, is subject
to inter-reader variability and disagreement. Consequently, a
number of recent DL approaches for prostate cancer grading
have been presented. Bulten et al. [210] and Strom et al. [211]
both recently published large cohort studies involving 1243
and 976 patients respectively, that DL approaches could be
used for achieving a performance of Gleason grading that was
comparable to pathologists [212].
Mutation identification and pathway association. Disease
morphology reflects the sum of all temporal genetic and
epigenetic changes and alterations within the disease.
Recognizing this, some groups have begun to explore the role
of DL approaches for identifying disease specific mutations
and associations with biological pathways. Oncotype DX is
a 21-gene expression assay that is prognostic and predictive
of benefit of adjuvant chemotherapy for early stage estrogen
receptor positive breast cancers. In two related studies [213],
[214], Romo-Bucheli showed that DL could be used to
identify tubule density and mitotic index from pathology
images and demonstrated a strong association between these
measurements with the Oncotype DX risk categories (low,
intermediate and high) for breast cancers. Interestingly,
tubule density and mitotic index are an important component
of breast cancer grading. Microsatellite instability (MSI)
is a condition that results from impaired DNA mismatch
repair. To assess whether a tumor is MSI, genetic or
immunohistochemical tests are required. A study by Kather
et al. [215] showed that DL could predict MSI from histology
images in gastrointestinal cancers with an AUC=0.84.
Coudray et al. [207] show that a DL network can be trained
to recognize many of the commonly mutated genes in
non-small cell lung adenocarcinoma. They showed that six of
these mutated genes—TK11, EGFR, FAT1, SETBP1, KRAS,
and TP53—can be predicted from pathology images, with
AUCs from 0.733 to 0.856.
Survival and disease outcome prediction. More recently,
there has been interest in applying DL algorithms to pathology
images to directly predict survival and disease outcome. In
a recent paper, Skrede et al. [216] performed a large study
of DL involving over 12M pathology image tiles from over
2000 patients to predict cancer specific survival in early stage
colorectal cancer patients. DL yielded a hazard ratio for poor
versus good prognosis of 3.84 (95% CI 2.72-5.43; p<0.0001)
in a validation cohort of 1122 patients and 3.04 (2.07-4.47;
p<0.0001) after adjusting for established prognostic markers
including T and N stage. Courtiol et al. [217] presented an
approach employing DL for predicting patient outcome in the
case of mesothelioma. Saillard et al. [218] used DL to predict
survival after hepatocellular carcinoma resection.
While the studies described above clearly reflect the grow-
ing influence and impact of DL on a variety of image analysis
and classification problems in digital pathology, there are
still concerns with regards to its interpretability, the need
for large training sets, the need for annotated data, and
generalizability. Attempts have been made to use approaches
like visual attention mapping [219] to provide some degree
of transparency with respect to where in the image the DL
network appears to be focusing its attention. Another approach
to imbue interpretability is via hybrid approaches, wherein
DL is used to identify specific primitives of interest (e.g.
lymphocytes) in the pathology images (in other words using it
as a detection and segmentation tool) and then deriving hand-
crafted features from these primitives (e.g. spatial patterns of
arrangement of lymphocytes) to perform prognosis and classi-
fication tasks [220], [221], [222]. However, as Bera et al. [201]
noted in a recent review article, while DL approaches might
be feasible for diagnostic indications, clinical tasks relating to
outcome prediction and treatment response might still involve
approaches that provide greater interpretability. While it seems
highly likely that research in DL and its application to digital
pathology are likely to continue to grow, it remains to be
seen how these approaches fare in a prospective and clinical
trial setting, which in turn might ultimately determine their
translation to the clinic.
III. DISCUSSION
Technical challenges ahead. In this overview paper, many
technological challenges across several medical domains and
tasks were reviewed. In general, most challenges are met
by continuous improvement of solutions to the well known
Data challenge. The community as a whole is continuously
developing and improving transfer learning based solutions
and data augmentation schemes. As systems are starting to be
implemented across datasets, hospitals, and countries, a new
spectrum of challenges is arising including System robustness
and Generalization across acquisition protocols, machines,
and hospitals. Here, data pre-processing, continuous model
learning, and fine-tuning across systems are a few of the new
developments ahead. Detailed reviews of the topics presented
herein, as well as additional topics, such as robustness to
adversarial attacks and interpretability, can be found in several
recent DL review articles such as [223].
How do we get new tools into the clinic? The question
whether DL tools are used in the clinic is often raised. This
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question is particularly relevant because results in many tasks
and challenges show radiologist-level performance. In several
recent works conducted to estimate the utility of AI-based
technology as an aid to the radiologist, it is consistently
shown that human experts with AI perform better than those
without AI [224]. The excitement in the field has led to the
emergence of many AI medical imaging startup companies.
Still, to date not much technology has evolved from research
to actual clinical use. There are a variety of reasons for this
including: users being cautious regarding the technology,
specifically the prospect of being replaced by AI; the need
to prove that the technology can address real user needs
and bring quantifiable benefits; regulatory pathways that are
long and costly, patient safety considerations, and economic
factors such as who will pay for AI tools.
The forecast going forward is that this is an emerging
field, with enormous promise going forward. How would we
get there? An interesting possibility is that the worldwide
experience with the COVID-19 pandemic will actually serve
to bridge the gap between the need and AI—with users eagerer
to receive support, and even the regulatory steps more adaptive
to facilitate a transition of general computational tools, with
COVID-AI related tools in particular. Within the last several
months, we saw several interesting advances: We experienced
the ability of AI to rapidly adapt from existing pretrained
models to new disease manifestations of COVID-19, using the
many tools described in this article and in [225], [105]. We
see strong and robust DL based solutions for COVID-19 detec-
tion, localization, quantification, and characterization starting
to support the initial diagnosis and more so the followup
of hospitalized patients. AI-based tools are being developed
to support the assessment of disease severity and, recently,
they are starting to provide tools for assessing treatment and
predicting treatment success [226], [227].
Future promise. As we envision future possibilities, one
immediate step forward is to combine the image with addi-
tional clinical context, from patient record to additional clinical
descriptors (such as blood tests, genomics, medications, vital
signs, and non-imaging data such as ECG). This step will
provide a transition from image space to patient-level infor-
mation. Collecting cohorts will enable population-level statis-
tical analysis to learn about disease manifestations, treatment
responses, adverse reactions from and interactions between
medications, and more. This step requires building complex
infrastructure, along with the generation of new privacy and
security regulations—between hospitals and academic research
institutes, across hospitals, and in multi-national consortia. As
more and more data become available, DL and AI will enable
unsupervised explorations within the data, thus providing for
new discoveries of drugs and treatments towards advancement
and augmentation of healthcare as we know it.
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